PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,234 | -46.6% | 131,068 | -3.1% | 0.00% | -50.0% |
| Q2 2023 | $5,498,462 | -65.1% | 135,197 | -58.4% | 0.00% | -71.4% |
| Q1 2023 | $15,738,156 | +18.3% | 324,900 | -6.8% | 0.01% | +16.7% |
| Q4 2022 | $13,299,344 | +112.2% | 348,424 | +179.0% | 0.01% | +100.0% |
| Q3 2022 | $6,268,000 | +69.0% | 124,870 | +34.9% | 0.00% | +50.0% |
| Q2 2022 | $3,708,000 | +7.4% | 92,550 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $3,453,000 | -6.1% | 92,550 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $3,678,000 | +7.0% | 92,350 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,436,000 | -12.5% | 92,350 | -0.6% | 0.00% | -50.0% |
| Q2 2021 | $3,929,000 | -95.2% | 92,950 | -94.6% | 0.00% | -94.4% |
| Q1 2021 | $81,297,000 | -24.9% | 1,716,937 | -3.2% | 0.04% | -29.4% |
| Q4 2020 | $108,229,000 | +33.2% | 1,773,367 | +2.0% | 0.05% | +15.9% |
| Q3 2020 | $81,282,000 | -3.7% | 1,738,658 | +4.5% | 0.04% | -12.0% |
| Q2 2020 | $84,421,000 | +18.2% | 1,663,800 | +3.9% | 0.05% | -2.0% |
| Q1 2020 | $71,416,000 | +1716.7% | 1,600,887 | +1855.9% | 0.05% | +2450.0% |
| Q4 2019 | $3,931,000 | +47.1% | 81,850 | +3.5% | 0.00% | 0.0% |
| Q3 2019 | $2,673,000 | -23.8% | 79,050 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $3,508,000 | +60.3% | 77,950 | +34.0% | 0.00% | +100.0% |
| Q1 2019 | $2,189,000 | -43.0% | 58,150 | -48.1% | 0.00% | -66.7% |
| Q4 2018 | $3,842,000 | +16.2% | 111,950 | +59.1% | 0.00% | +50.0% |
| Q3 2018 | $3,306,000 | +39.3% | 70,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,373,000 | +77.8% | 70,350 | +42.6% | 0.00% | +100.0% |
| Q1 2018 | $1,335,000 | +62.2% | 49,350 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $823,000 | -16.6% | 49,350 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $987,000 | +9.1% | 49,350 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $905,000 | +47.2% | 49,350 | -21.1% | 0.00% | – |
| Q1 2017 | $615,000 | -19.1% | 62,550 | -10.2% | 0.00% | -100.0% |
| Q4 2016 | $760,000 | -22.1% | 69,650 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $976,000 | +83.8% | 69,650 | -7.9% | 0.00% | – |
| Q2 2016 | $531,000 | +56.2% | 75,650 | +43.4% | 0.00% | – |
| Q1 2016 | $340,000 | -99.2% | 52,750 | -95.9% | 0.00% | -100.0% |
| Q4 2015 | $41,650,000 | +51.3% | 1,285,485 | +24.7% | 0.04% | +45.8% |
| Q3 2015 | $27,531,000 | -26.9% | 1,031,124 | +31.7% | 0.02% | -22.6% |
| Q2 2015 | $37,678,000 | +190.7% | 782,842 | +267.5% | 0.03% | +181.8% |
| Q1 2015 | $12,962,000 | +649.7% | 213,010 | +537.8% | 0.01% | +1000.0% |
| Q4 2014 | $1,729,000 | +26.8% | 33,400 | +7.7% | 0.00% | 0.0% |
| Q3 2014 | $1,364,000 | +68.4% | 31,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $810,000 | +26900.0% | 31,000 | +27578.6% | 0.00% | – |
| Q1 2014 | $3,000 | +50.0% | 112 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 112 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |